THE EFFICACY OF FOURTEEN-DAYS ESOMEPRAZOLE AND AMOXICILLIN CONTAINING HIGH DOSE DUAL THERAPY IN THE TREATMENT OF FIRST-LINE ANTI-H. PYLORI THERAPY: A PROSPECTIVE RANDOMIZED TRIAL

被引：0
|
作者：
Huang, Pao-Yuan
Ma, Te-Ling
Tai, Wei-Chen
Liang, Chih-Ming
Wu, Keng-Liang
Chuah, Seng-Kee
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
436
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [31] EFFICACY OF HIGH-DOSE DUAL THERAPY VERSUS BISMUTH-CONTAINING QUADRUPLE THERAPY FOR FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION AND AN INTERIM REPORT OF MULTI-CENTER, RANDOMIZED CONTROL STUDY
    Hu, Chi-Tan
    Tung, Chien-Chih
    Lin, Chun-Jung
    Kuo, I-Nan
    Lin, Bor-Ru
    Wang, Hong-Long
    Chen, Jin-De
    Cheng, Mu-Liang
    Shun, Chia-Tung
    Li, Huei-Mi
    Hung, Jui-Sheng
    Lei, Wei-Yi
    Shieh, Ming Jium
    Wong, Jau-Min
    Kao, John Y.
    Yang, Jyh-Chin
    GASTROENTEROLOGY, 2017, 152 (05) : S182 - S183
  • [32] Effectiveness and safety of high-dose dual therapy PPI-amoxicillin dual therapy for first-line Helicobacter pylori in Chile: Experience from the retrospective study
    Quera, Rodrigo
    Cordova, Andrea
    Nunez, Paulina
    von Muhlenbrock, Christian
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (10): : 806 - 808
  • [33] High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
    Yang, Jyh-Chin
    Lin, Chun-Jung
    Wang, Hong-Long
    Chen, Jin-De
    Kao, John Y.
    Shun, Chia-Tung
    Lu, Chien-Wei
    Lin, Bor-Ru
    Shieh, Ming-Jium
    Chang, Ming-Chu
    Chang, Yu-Ting
    Wei, Shu-Chen
    Lin, Lin-Chih
    Yeh, Wen-Chun
    Kuo, Jen-Shin
    Tung, Chien-Chih
    Leong, Yew-Loong
    Wang, Teh-Hong
    Wong, Jau-Min
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (05) : 895 - U574
  • [34] Two-week Triple Therapy with either Standard or High-dose Esomeprazole for First-line H. pylori Eradication
    De Francesco, Vincenzo
    Ridola, Lorenzo
    Hassan, Cesare
    Bellesia, Annamaria
    Alvaro, Domenico
    Vaira, Dino
    Zullo, Angelo
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2016, 25 (02) : 147 - 150
  • [35] 14-day sequential therapy versus 10-day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicenter, non-inferiority, randomized trial
    Chen, Po-Yueh
    Chen, Mei-Jyh
    Fang, Yu-Jen
    Lin, Jaw-Town
    Wu, Ming-Shiang
    Liou, Jyh-Ming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 358 - 358
  • [36] Vonoprazan and high-dose amoxicillin dual therapy for Helicobacter pylori first-line eradication: A single-arm, interventional study
    Sue, Soichiro
    Kondo, Masaaki
    Sato, Takeshi
    Oka, Hiroyuki
    Sanga, Katsuyuki
    Ogashiwa, Tsuyoshi
    Matsubayashi, Mao
    Kaneko, Hiroaki
    Irie, Kuniyasu
    Maeda, Shin
    JGH OPEN, 2023, 7 (01): : 55 - 60
  • [37] EFFICACY OF 7-DAY VONOPRAZAN AND AMOXICILLIN DUAL THERAPY AS FIRST-LINE HELICOBACTER PYLORI TREATMENT: PROTOCOL OF MULTI-CENTER, NON-INFERIORITY, RANDOMIZED CONTROL TRIAL
    Suzuki, Sho
    Gotoda, Takuji
    Shibuya, Hitoshi
    Kusano, Chika
    Ikehara, Hisatomo
    Ichijima, Ryoji
    Kawabe, Koichi
    Kasai, Toyotaka
    Eto, Hiroyuki
    Yoda, Yoshioki
    Ohtaka, Masahiko
    Ohyauchi, Motoki
    Ito, Hirotaka
    Kawamura, Masashi
    Ogata, Yohei
    Nakahara, Moriyasu
    GUT, 2019, 68 : A87 - A88
  • [38] Ten-Day Vonoprazan-Amoxicillin Dual Therapy as a First-Line Treatment of Helicobacter pylori Infection Compared With Bismuth-Containing Quadruple Therapy
    Qian, Hai-Sheng
    Li, Wen-Jie
    Dang, Yi-Ni
    Li, Lu-Rong
    Xu, Xiao-Bing
    Yuan, Lin
    Zhang, Wei-Feng
    Yang, Zhen
    Gao, Xin
    Zhang, Min
    Li, Xuan
    Zhang, Guo-Xin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (04): : 627 - 634
  • [39] Bismuth containing quadruple and concomitant therapy for 2 weeks are effective for the first-line Helicobacter pylori eradication: A prospective randomized trial
    Woo, H.
    Chung, J.
    Kim, S.
    Kim, J.
    Kwon, K.
    Kim, K.
    Kim, Y.
    Park, D.
    HELICOBACTER, 2017, 22
  • [40] Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori
    Castro-Fernandez, M.
    Lamas, E.
    Perez-Pastor, A.
    Pabon, M.
    Aparcero, R.
    Vargas-Romero, J.
    Larraona, J. L.
    Romero-Gomez, M.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2009, 101 (06) : 395 - 398
12345